The Impact of Obesity on Children and Adolescents.

NCT ID: NCT01231152

Last Updated: 2012-05-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-09-30

Study Completion Date

2012-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to investigate the association of obesity with arterial blood pressure, atherosclerosis, target organ damage (heart, arteries, kidney) and insulin resistance in children and young adolescents.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity Cardiovascular Risk Factors

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Overweight (85th\<BMI\<95th percentile) and obese (BMI\>=95th percentile) children and adolescents
* No medication treatment (apart from bronchodilators, T4 in euthyroid children)
* No severe mental problem
* Parents' and patients' signed consent

Exclusion Criteria

* Severe chronic or acute cardiac disease or other severe chronic or acute disease
* Any acute inflammation
* Familial dyslipidemia
* Clinical hypothyroidism or other endocrinopathy
* Poor compliance.
Minimum Eligible Age

8 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Athens

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

George S. Stergiou

Associate Professor of Medicine and Hypertension

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

George S Stergiou

Role: PRINCIPAL_INVESTIGATOR

University of Athens

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hypertension Center, Third Department of Medicine, University of Athens

Athens, , Greece

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Greece

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

George S Stergiou, MD

Role: primary

+302107763117

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

OB10

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Metabolically Healthy Obese
NCT06032312 UNKNOWN
Leipzig Childhood Obesity Study
NCT04491344 RECRUITING